Ayodele Erinle, MD
Emergency Medicine · Gallup, NMNPI 1235183492
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Kedplasma LLC at 44.1% of the total. Reporting peaked in 2022 at $447 and has fallen 73.9% since, to $117 in 2025. Among emergency medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $92.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kedplasma LLC$447
- Akebia Therapeutics Inc$224
- AstraZeneca$135
- Baxter Healthcare$93
- Vertex$53
- Mozarc Medical US LLC$45
- plus $17 from 1 others
Across 69 payments — averaging $4252.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$136K
- Akebia Therapeutics Inc$124K
- Grifols, S.A.$16K
- AstraZeneca$10K
- AbbVie$6K
- CSL Behring$2K
What the payments were for
- Consulting fees$44744%
- Food & beverage$56656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kedplasma LLC | 1 | $447 |
| Akebia Therapeutics Inc | 2 | $224 |
| AstraZeneca | 1 | $135 |
| Baxter Healthcare | 2 | $93 |
| Vertex | 1 | $53 |
| Mozarc Medical US LLC | 3 | $45 |
| Ardelyx, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,013 in reported general payments places this provider in the 95th percentile of 367 emergency medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 31 | $31,345 |
| Sevelamer Carbonate | 15 | $3,788 |
| Bumetanide | 16 | $1,074 |
| Losartan Potassium | 14 | $240 |
| Lisinopril | 21 | $197 |
| Carvedilol | 13 | $183 |
| Amlodipine Besylate | 13 | $143 |
| Allopurinol | 16 | $143 |
| Furosemide | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $135 | $31,34531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 367 emergency medicine providers in New Mexico.
Other emergency medicine in Gallup
- Ashley SullivanGallup$129
- Dorothy HabratRio Rancho$11K
- Jonathan MarinaroAlbuquerque$8K
- Julie KanterAlbuquerque$8K
- James CottonAlbuquerque$7K
- Ethan SimsAlbuquerque$4K
- Robert AlundayAlbuquerque$4K
- David SklarAlbuquerque$3K
- Michael LaraLas Cruces$1K
- Marshall BacaArtesia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.